Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.

Your browser appears to have cookies disabled. For the best experience of this website, please enable cookies in your browser

We'll assume we have your consent to use cookies, for example so you won't need to log in each time you visit our site.
Learn more

New test hope for prostate cancer

  • 1 Comment

A simple non-invasive test of semen may in the future be used to diagnose prostate cancer, according to research published in the journal Organic and Biomolecular Chemistry.

A team of scientists from Durham University and the US have perfected a means of measuring the wavelength of light passing through a diluted sample of prostate fluid.

This detects citrate, an indicator of prostate cancer that reduces sharply from a normal 50 to 200 millimoles to between two and 20 millimoles in men with the disease.

The three-minute test could replace the current standard procedure, which uses biopsy samples obtained by inserting a needle into the prostate gland.

At present, because the standard prostate specific antigen test can give false results, patients may either be wrongly diagnosed with the disease or it may be missed altogether.

And because there is no reliable test there is no national screening programme, which results in the deaths of 10,000 of the 35,000 diagnosed with the condition every year.

  • 1 Comment

Readers' comments (1)

  • The death rate for this disease, is frightening, l only hope that the government put as much effort into reducing these figures as they have for breast and cervical cancer in women.

    Unsuitable or offensive? Report this comment

Have your say

You must sign in to make a comment

Please remember that the submission of any material is governed by our Terms and Conditions and by submitting material you confirm your agreement to these Terms and Conditions. Links may be included in your comments but HTML is not permitted.